Adlai Nortye Ltd. (ANL)
Nasdaq: ANL · Pharmaceutical Preparations · North Brunswick, NJ · filing with the SEC since 2022
Who runs Adlai Nortye Ltd.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Lu Yang
CEO. First filing May 2026, latest May 21, 2026, 1 filing in all.
Officers reporting now
4
of 8 people with a filing in the last fifteen months
Directors reporting now
4
8 people on the record since 2026
Officerssales are open-market, Oct 1, 2025 to Oct 1, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Ye Xiaofeng | CFO | Jun 2026 | Aug 26, 2026 | 2 · $200,000 |
| Lu Yang | CEO | May 2026 | May 21, 2026 | 1 · $0.00 |
| Tse Archie | President, Head of R&D | May 2026 | May 20, 2026 | none |
| Tang Kaiyang | President,Adlai Nortye USA INC | May 2026 | May 14, 2026 | none |
Directorssales are open-market, Oct 1, 2025 to Oct 1, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Ji Ping | director | Apr 2026 | Oct 1, 2026 | 4 · $200,000 |
| Birgerson Lars Erik | director | Aug 2026 | Aug 4, 2026 | none |
| Sawhney Roger | director | Jul 2026 | Jul 15, 2026 | none |
| Tse Alan Ming Lun | director | May 2026 | May 28, 2026 | none |
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.